{"transactions":[{"id":1542382,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":92024,"kind":"person","name":"Arthur David J.","position":1,"cik":"0001769331","reported_name":"Arthur David J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-04-12T20:50:27.000Z","date":"2024-04-11","kind":"grant","planned":false,"acquired":true,"shares":20500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":20500,"derivative":{"exercise_price":0.51,"exercise_date":"2025-04-11","expiration_date":"2034-04-11","underlying":"Common Stock","underlying_shares":20500},"source":{"system":"sec-edgar","filing":"0001615219-24-000034","document":"wk-form4_1712955014.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000161521924000034/wk-form4_1712955014.xml","form_type":"4"}},{"id":2013176,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":92024,"kind":"person","name":"Arthur David J.","position":1,"cik":"0001769331","reported_name":"Arthur David J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-02-15T21:04:16.000Z","date":"2023-02-13","kind":"grant","acquired":true,"shares":14300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock granted under the Salarius Pharmaceuticals, Inc. 2015 Equity Incentive Plan in lieu of cash for performance bonus. The shares of common stock are subject to a six-month holding period pursuant to the terms of the restricted stock agreement."}],"balance_after":48019,"source":{"system":"sec-edgar","filing":"0001615219-23-000023","document":"wf-form4_167649503732734.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000161521923000023/wf-form4_167649503732734.xml","form_type":"4"}},{"id":2061688,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":92024,"kind":"person","name":"Arthur David J.","position":1,"cik":"0001769331","reported_name":"Arthur David J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-01-05T22:33:03.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock granted under the Salarius Pharmaceuticals, Inc.2015 Equity Incentive Plan. 25% of the shares of restricted stock will vest on January 2, 2024, and 1/36 of the remaining shares of restricted stock will vest on monthly anniversary thereafter."}],"balance_after":33719,"source":{"system":"sec-edgar","filing":"0001615219-23-000002","document":"wf-form4_167295795521891.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000161521923000002/wf-form4_167295795521891.xml","form_type":"4"}},{"id":2089284,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":92024,"kind":"person","name":"Arthur David J.","position":1,"cik":"0001769331","reported_name":"Arthur David J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-12-12T23:34:44.000Z","date":"2022-11-03","kind":"grant","acquired":true,"shares":2693,"price":1.734,"value":4669.662,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person's previous Form 4 filed on November 7, 2022 and amended on November 8, 2022 incorrectly reported the Reporting Person acquiring 10,000 shares of common stock under the Salarius Pharmaceuticals, Inc. 2015 Employee Stock Purchase Plan, as amended, in transactions that were exempt under both Rule 16b-3(d) and Rule Rule 16b-3(c), when it should have been reported as 2,693 shares of common stock."}],"balance_after":13719,"source":{"system":"sec-edgar","filing":"0001615219-22-000155","document":"wf-form4a_167088805437684.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000161521922000155/wf-form4a_167088805437684.xml","form_type":"4/A","original_submission_date":"2022-11-07"}},{"id":2121998,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":92024,"kind":"person","name":"Arthur David J.","position":1,"cik":"0001769331","reported_name":"Arthur David J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-11-08T22:42:33.000Z","date":"2022-11-03","kind":"grant","acquired":true,"shares":10000,"price":1.734,"value":17340.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired under the Salarius Pharmaceuticals, Inc. 2015 Employee Stock Purchase Plan, as amended, in transactions that were exempt under both Rule 16b-3(d) and Rule Rule 16b-3(c)"}],"balance_after":21026,"source":{"system":"sec-edgar","filing":"0001615219-22-000144","document":"wf-form4a_166794733755240.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000161521922000144/wf-form4a_166794733755240.xml","form_type":"4/A","original_submission_date":"2022-11-07"}},{"id":2123180,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":92024,"kind":"person","name":"Arthur David J.","position":1,"cik":"0001769331","reported_name":"Arthur David J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-11-07T21:34:56.000Z","date":"2022-11-03","kind":"grant","acquired":true,"shares":10000,"price":1.734,"value":17340.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired under the Salarius Pharmaceuticals, Inc. 2015 Employee Stock Purchase Plan, as amended, in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":285674,"source":{"system":"sec-edgar","filing":"0001615219-22-000142","document":"wf-form4_166785687791752.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000161521922000142/wf-form4_166785687791752.xml","form_type":"4"}},{"id":2250870,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":92024,"kind":"person","name":"Arthur David J.","position":1,"cik":"0001769331","reported_name":"Arthur David J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-05-31T21:17:24.000Z","date":"2022-05-26","kind":"purchase","acquired":true,"shares":10800,"price":0.1843,"value":1990.44,"ownership":{"direct":false,"nature":"By daughter"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose."}],"balance_after":303574,"source":{"system":"sec-edgar","filing":"0001615219-22-000087","document":"wf-form4_165403182105530.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000161521922000087/wf-form4_165403182105530.xml","form_type":"4"}},{"id":2250869,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":92024,"kind":"person","name":"Arthur David J.","position":1,"cik":"0001769331","reported_name":"Arthur David J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-05-31T21:17:24.000Z","date":"2022-05-26","kind":"purchase","acquired":true,"shares":10392,"price":0.1799,"value":1869.5208,"ownership":{"direct":false,"nature":"By son"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose."}],"balance_after":292774,"source":{"system":"sec-edgar","filing":"0001615219-22-000087","document":"wf-form4_165403182105530.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000161521922000087/wf-form4_165403182105530.xml","form_type":"4"}},{"id":2250868,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":92024,"kind":"person","name":"Arthur David J.","position":1,"cik":"0001769331","reported_name":"Arthur David J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-05-31T21:17:24.000Z","date":"2022-05-26","kind":"purchase","acquired":true,"shares":708,"price":0.18,"value":127.44,"ownership":{"direct":false,"nature":"By son"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose."}],"balance_after":282382,"source":{"system":"sec-edgar","filing":"0001615219-22-000087","document":"wf-form4_165403182105530.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000161521922000087/wf-form4_165403182105530.xml","form_type":"4"}},{"id":2250867,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":92024,"kind":"person","name":"Arthur David J.","position":1,"cik":"0001769331","reported_name":"Arthur David J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-05-31T21:17:24.000Z","date":"2022-05-26","kind":"purchase","acquired":true,"shares":18600,"price":0.182,"value":3385.2,"ownership":{"direct":true},"balance_after":281674,"source":{"system":"sec-edgar","filing":"0001615219-22-000087","document":"wf-form4_165403182105530.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000161521922000087/wf-form4_165403182105530.xml","form_type":"4"}},{"id":2250866,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":92024,"kind":"person","name":"Arthur David J.","position":1,"cik":"0001769331","reported_name":"Arthur David J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-05-31T21:17:24.000Z","date":"2022-05-26","kind":"purchase","acquired":true,"shares":3400,"price":0.18,"value":612.0,"ownership":{"direct":true},"balance_after":263074,"source":{"system":"sec-edgar","filing":"0001615219-22-000087","document":"wf-form4_165403182105530.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000161521922000087/wf-form4_165403182105530.xml","form_type":"4"}},{"id":2280503,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":92024,"kind":"person","name":"Arthur David J.","position":1,"cik":"0001769331","reported_name":"Arthur David J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-05-05T20:06:21.000Z","date":"2022-05-03","kind":"grant","acquired":true,"shares":10000,"price":0.1863,"value":1863.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person voluntarily agreed to receive a percentage of his base salary in issuer shares  and receive these shares in lieu of net cash compensation. Shares are  purchased at a  price determined pursuant to the issuer's Employee Stock Purchase Plan."}],"balance_after":259674,"source":{"system":"sec-edgar","filing":"0001615219-22-000069","document":"wf-form4_165178116032585.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000161521922000069/wf-form4_165178116032585.xml","form_type":"4"}},{"id":2341098,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":92024,"kind":"person","name":"Arthur David J.","position":1,"cik":"0001769331","reported_name":"Arthur David J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-03-09T21:01:55.000Z","date":"2022-03-03","kind":"purchase","acquired":true,"shares":139488,"price":0.391,"value":54539.808,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Registrant issued these shares to the reporting person as part of his bonus; which shares were issued in lieu of net cash compensation. The shares were issued at the fair market value of the Registrants common stock on the date of grant."}],"balance_after":249674,"source":{"system":"sec-edgar","filing":"0001615219-22-000018","document":"wf-form4_164685969931166.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000161521922000018/wf-form4_164685969931166.xml","form_type":"4"}},{"id":2428519,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":92024,"kind":"person","name":"Arthur David J.","position":1,"cik":"0001769331","reported_name":"Arthur David J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-01-21T21:08:11.000Z","date":"2022-01-20","kind":"grant","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the options are fully vested on January 19, 2023, and 1/36 of the remaining options vest on each monthly anniversary thereafter."}],"balance_after":500000,"derivative":{"exercise_price":0.48,"expiration_date":"2032-01-19","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001615219-22-000008","document":"wf-form4_164279927781443.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000161521922000008/wf-form4_164279927781443.xml","form_type":"4"}},{"id":2522471,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":92024,"kind":"person","name":"Arthur David J.","position":1,"cik":"0001769331","reported_name":"Arthur David J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-11-05T18:58:04.000Z","date":"2021-11-03","kind":"grant","acquired":true,"shares":7939,"price":0.718,"value":5700.202,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person voluntarily agreed to receive a percentage of his base salary in issuer shares and receive these shares in lieu of net cash compensation. Shares are purchased at a price determined pursuantto the issuer's Employee Stock Purchase Plan."}],"balance_after":110186,"source":{"system":"sec-edgar","filing":"0001615219-21-000096","document":"wf-form4_163613866819461.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000161521921000096/wf-form4_163613866819461.xml","form_type":"4"}},{"id":2599270,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":92024,"kind":"person","name":"Arthur David J.","position":1,"cik":"0001769331","reported_name":"Arthur David J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-08-17T20:08:52.000Z","date":"2021-08-17","kind":"purchase","acquired":true,"shares":2000,"price":0.892,"value":1784.0,"ownership":{"direct":false,"nature":"By son"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose"}],"balance_after":102247,"source":{"system":"sec-edgar","filing":"0001615219-21-000087","document":"wf-form4_162923091089935.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000161521921000087/wf-form4_162923091089935.xml","form_type":"4"}},{"id":2599269,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":92024,"kind":"person","name":"Arthur David J.","position":1,"cik":"0001769331","reported_name":"Arthur David J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-08-17T20:08:52.000Z","date":"2021-08-17","kind":"purchase","acquired":true,"shares":2000,"price":0.899,"value":1798.0,"ownership":{"direct":false,"nature":"By daughter"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose"}],"balance_after":100247,"source":{"system":"sec-edgar","filing":"0001615219-21-000087","document":"wf-form4_162923091089935.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000161521921000087/wf-form4_162923091089935.xml","form_type":"4"}},{"id":2726400,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":92024,"kind":"person","name":"Arthur David J.","position":1,"cik":"0001769331","reported_name":"Arthur David J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-05-05T21:10:05.000Z","date":"2021-05-03","kind":"grant","acquired":true,"shares":9822,"price":0.567,"value":5569.074,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person voluntarily agreed to receive a percentage of his base salary in issuer shares and receive these shares in lieu of net cash compensation. Shares are purchased at a price determined pursuant to the issuer's Employee Stock Purchase Plan."}],"balance_after":96247,"source":{"system":"sec-edgar","filing":"0001615219-21-000040","document":"wf-form4_162024898808755.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000161521921000040/wf-form4_162024898808755.xml","form_type":"4"}},{"id":2956220,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":92024,"kind":"person","name":"Arthur David J.","position":1,"cik":"0001769331","reported_name":"Arthur David J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-12-04T22:05:05.000Z","date":"2020-12-02","kind":"grant","acquired":true,"shares":275000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the options are fully vested on December 1, 2021, and 1/36 of the remaining options vest on each monthly anniversary thereafter."}],"balance_after":275000,"derivative":{"exercise_price":0.74,"expiration_date":"2030-12-01","underlying":"Common Stock","underlying_shares":275000},"source":{"system":"sec-edgar","filing":"0001615219-20-000122","document":"wf-form4_160711949187470.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000161521920000122/wf-form4_160711949187470.xml","form_type":"4"}},{"id":2990794,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":92024,"kind":"person","name":"Arthur David J.","position":1,"cik":"0001769331","reported_name":"Arthur David J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-11-05T22:44:03.000Z","date":"2020-11-03","kind":"grant","acquired":true,"shares":4879,"price":0.561,"value":2737.119,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person voluntarily agreed to receive a percentage of his base salary in issuer shares  and receive these shares in lieu of net cash compensation. Shares are purchased at a  price determined pursuant to the issuer's Employee Stock Purchase Plan."}],"balance_after":86425,"source":{"system":"sec-edgar","filing":"0001615219-20-000106","document":"wf-form4_160461622928134.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000161521920000106/wf-form4_160461622928134.xml","form_type":"4"}},{"id":3050675,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":92024,"kind":"person","name":"Arthur David J.","position":1,"cik":"0001769331","reported_name":"Arthur David J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-08-20T11:59:41.000Z","date":"2020-08-19","kind":"purchase","acquired":true,"shares":1000,"price":1.01,"value":1010.0,"ownership":{"direct":false,"nature":"By son"},"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001615219-20-000095","document":"wf-form4_159792476762012.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000161521920000095/wf-form4_159792476762012.xml","form_type":"4"}},{"id":3050674,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":92024,"kind":"person","name":"Arthur David J.","position":1,"cik":"0001769331","reported_name":"Arthur David J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-08-20T11:59:41.000Z","date":"2020-08-19","kind":"purchase","acquired":true,"shares":1000,"price":1.01,"value":1010.0,"ownership":{"direct":false,"nature":"By daughter"},"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001615219-20-000095","document":"wf-form4_159792476762012.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000161521920000095/wf-form4_159792476762012.xml","form_type":"4"}},{"id":3081449,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":92024,"kind":"person","name":"Arthur David J.","position":1,"cik":"0001769331","reported_name":"Arthur David J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-07-17T00:56:38.000Z","date":"2020-07-14","kind":"grant","acquired":true,"shares":339584,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the options are fully vested on July 14, 2021, and 1/36 of the remaining options vest on each monthly anniversary thereafter."}],"balance_after":339584,"derivative":{"exercise_price":1.32,"expiration_date":"2030-07-13","underlying":"Common Stock","underlying_shares":339584},"source":{"system":"sec-edgar","filing":"0001615219-20-000081","document":"wf-form4_159494738307174.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000161521920000081/wf-form4_159494738307174.xml","form_type":"4"}},{"id":3194955,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":92024,"kind":"person","name":"Arthur David J.","position":1,"cik":"0001769331","reported_name":"Arthur David J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-03-25T22:02:21.000Z","date":"2020-03-23","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the options granted are fully vested on March 23, 2021, and quarterly vesting of the remaining options over 3 years."}],"balance_after":60000,"derivative":{"exercise_price":0.61,"expiration_date":"2030-03-22","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001615219-20-000025","document":"wf-form4_158517372311926.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000161521920000025/wf-form4_158517372311926.xml","form_type":"4"}},{"id":3273356,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":92024,"kind":"person","name":"Arthur David J.","position":1,"cik":"0001769331","reported_name":"Arthur David J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Warrants (right to buy)","published_at":"2020-02-14T02:07:23.000Z","date":"2020-02-11","kind":"purchase","acquired":true,"shares":2175,"price":0.01,"value":21.75,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Reporting Person acquired these securities in the Issuer's public offering of Class A Units on February 11, 2020. Each Class A Unit consisted of one share of Common Stock and one warrant to purchase a single share of Common Stock."}],"balance_after":2175,"derivative":{"exercise_price":1.15,"exercise_date":"2020-02-11","expiration_date":"2025-02-11","underlying":"Common Stock","underlying_shares":2175},"source":{"system":"sec-edgar","filing":"0000899243-20-004567","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000089924320004567/doc4.xml","form_type":"4"}},{"id":3276181,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":92024,"kind":"person","name":"Arthur David J.","position":1,"cik":"0001769331","reported_name":"Arthur David J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-02-13T02:32:05.000Z","date":"2020-02-11","kind":"purchase","acquired":true,"shares":2175,"price":1.15,"value":2501.25,"ownership":{"direct":true},"balance_after":81546,"source":{"system":"sec-edgar","filing":"0000899243-20-004413","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000089924320004413/doc4.xml","form_type":"4"}},{"id":3414727,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":92024,"kind":"person","name":"Arthur David J.","position":1,"cik":"0001769331","reported_name":"Arthur David J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-09-13T10:16:54.000Z","date":"2019-09-10","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The grant has a 4-year vesting schedule with 25% vesting on September 30, 2020 and 1/12th of the balance vesting on the last day of each calendar quarter thereafter."}],"balance_after":30000,"derivative":{"exercise_price":8,"expiration_date":"2029-09-10","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001615219-19-000039","document":"wf-form4_156836979901866.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000161521919000039/wf-form4_156836979901866.xml","form_type":"4"}}]}